UPDATE 1-Illumina Q2 profit tops estimates

* Q2 adj EPS $0.26 vs. est $0.23

* Q2 rev $212 mln vs. est $193.9 mln

* Sees 2010 rev growth of about 28 pct

* Sees 2010 adj EPS $0.93-$1.00

* Shares up 3.3 pct after-hours trade

July 27 (Reuters) - Illumina Inc (ILMN.O), which makes tools for genetic analysis, posted a stronger-than-expected quarterly profit, helped by higher product revenue, and raised the lower end of its 2010 profit view.

Second-quarter net income was $29.8 million, or 21 cents a share, compared to $24.7 million, or 18 cents a share in the year-ago period. [ID:nASA00KBM]

Excluding special items, the company earned 26 cents a share.

Revenue for the quarter rose 31 percent to $212.0 million.

Analysts were expecting the company to earn 23 cents a share, on revenue of $193.9 million, according to Thomson Reuters I/B/E/S.

For 2010, the company expects to earn 93 cents to $1.00 a share, excluding items, compared with its prior view of 90 cents to $1.00 a share. [ID:nASA00A41]

Revenue growth for the full year is expected to be about 28 percent from last year's revenue of $666 million. It had previously expected revenue to grow 20 percent.

Analysts on average expected full year earnings of 99 cents a share, on revenue of $823.7 million.

Shares of the company were up 3.3 percent to $42.62 in after-hours trade. They closed at $41.26 Tuesday on Nasdaq. (Reporting by Krishnakali Sengupta in Bangalore; Editing by Aradhana Aravindan)